• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼古丁诱导的肺鳞状细胞癌中PD-L1表达是由α7-烟碱型乙酰胆碱受体/信号转导和转录激活因子3信号通路介导的。

Nicotine-induced PD-L1 expression in lung squamous cell carcinoma is mediated by the α7-nAChR/STAT3 signaling pathway.

作者信息

Li Yinan, Wang Wenting, Wang Yaoyao, Zhou Ce, Zou Xin, Wang Yixuan, Wang Ning

机构信息

Department of Respiratory and Critical Medicine, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.

Department of Oncology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.

出版信息

Transl Cancer Res. 2025 Jul 30;14(7):4293-4304. doi: 10.21037/tcr-2024-2587. Epub 2025 Jun 19.

DOI:10.21037/tcr-2024-2587
PMID:40792169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12335717/
Abstract

BACKGROUND

Nicotine, the principal addictive component of tobacco smoke, promotes lung cancer cell proliferation via α7 nicotinic acetylcholine receptors (α7-nAChRs). Programmed death-ligand 1 (PD-L1) serves as a crucial predictive biomarker for immune checkpoint inhibitor (ICI) therapy in lung squamous cell carcinoma (LUSC). This study aimed to investigate the expression patterns of α7-nAChR and its encoding gene in LUSC tissues, and to evaluate their associations with PD-L1 expression.

METHODS

expression, its correlation with clinicopathological features, and survival outcomes in LUSC were analyzed using The Cancer Genome Atlas (TCGA) database and Kaplan-Meier plotter. The expression levels of α7-nAChR and PD-L1 in LUSC tissues and cell lines were evaluated by immunohistochemistry and Western blot (WB). Following nicotine stimulation and small interfering RNA (siRNA) transfection, messenger RNA (mRNA) expression levels of , signal transducer and activator of transcription 3 (STAT3), and CD274 (PD-L1) were quantified using quantitative real-time polymerase chain reaction (qRT-PCR), while their protein levels were assessed by WB.

RESULTS

expression was significantly elevated in LUSC tissues and cell lines compared to adjacent normal tissues and bronchial epithelial cell lines (P<0.05), and correlated with smoking status. Higher expression was associated with shorter overall survival. Nicotine stimulation (1.0 μM) significantly increased the mRNA expression levels of , STAT3, and CD274 in LUSC cell lines. Knockdown of siRNA-mediated in LUSC cell lines decreased STAT3 phosphorylation (pSTAT3) and PD-L1 protein levels, while attenuating nicotine-induced PD-L1 upregulation. STAT3 silencing had no significant effect on α7-nAChR protein expression but downregulated PD-L1 protein levels and attenuated nicotine-induced PD-L1 upregulation.

CONCLUSIONS

α7-nAChR and its encoding gene are upregulated in LUSC tissue and are associated with smoking status. Patients with high expression of have a relatively worse prognosis. Nicotine may upregulate PD-L1 expression in LUSC through the α7-nAChR/STAT3 pathway.

摘要

背景

尼古丁是烟草烟雾中的主要成瘾成分,通过α7烟碱型乙酰胆碱受体(α7-nAChRs)促进肺癌细胞增殖。程序性死亡配体1(PD-L1)是肺鳞状细胞癌(LUSC)免疫检查点抑制剂(ICI)治疗的关键预测生物标志物。本研究旨在调查α7-nAChR及其编码基因在LUSC组织中的表达模式,并评估它们与PD-L1表达的相关性。

方法

使用癌症基因组图谱(TCGA)数据库和Kaplan-Meier绘图仪分析LUSC中α7-nAChR的表达、其与临床病理特征的相关性以及生存结果。通过免疫组织化学和蛋白质印迹(WB)评估LUSC组织和细胞系中α7-nAChR和PD-L1的表达水平。在尼古丁刺激和小干扰RNA(siRNA)转染后,使用定量实时聚合酶链反应(qRT-PCR)定量α7-nAChR、信号转导和转录激活因子3(STAT3)和CD274(PD-L1)的信使核糖核酸(mRNA)表达水平,同时通过WB评估它们的蛋白质水平。

结果

与相邻正常组织和支气管上皮细胞系相比,LUSC组织和细胞系中α7-nAChR的表达显著升高(P<0.05),且与吸烟状态相关。较高的α7-nAChR表达与较短的总生存期相关。尼古丁刺激(1.0 μM)显著增加了LUSC细胞系中α7-nAChR、STAT3和CD274的mRNA表达水平。在LUSC细胞系中敲低siRNA介导的α7-nAChR可降低STAT3磷酸化(pSTAT3)和PD-L1蛋白水平,同时减弱尼古丁诱导的PD-L1上调。STAT3沉默对α7-nAChR蛋白表达无显著影响,但下调了PD-L1蛋白水平并减弱了尼古丁诱导的PD-L1上调。

结论

α7-nAChR及其编码基因在LUSC组织中上调,且与吸烟状态相关。α7-nAChR高表达的患者预后相对较差。尼古丁可能通过α7-nAChR/STAT3途径上调LUSC中PD-L1的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/1c8946b644e3/tcr-14-07-4293-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/a3cf95fee83b/tcr-14-07-4293-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/a31a6c514020/tcr-14-07-4293-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/ad2c784bd7d0/tcr-14-07-4293-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/1c8946b644e3/tcr-14-07-4293-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/a3cf95fee83b/tcr-14-07-4293-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/a31a6c514020/tcr-14-07-4293-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/ad2c784bd7d0/tcr-14-07-4293-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f580/12335717/1c8946b644e3/tcr-14-07-4293-f4.jpg

相似文献

1
Nicotine-induced PD-L1 expression in lung squamous cell carcinoma is mediated by the α7-nAChR/STAT3 signaling pathway.尼古丁诱导的肺鳞状细胞癌中PD-L1表达是由α7-烟碱型乙酰胆碱受体/信号转导和转录激活因子3信号通路介导的。
Transl Cancer Res. 2025 Jul 30;14(7):4293-4304. doi: 10.21037/tcr-2024-2587. Epub 2025 Jun 19.
2
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.整合素 αVβ1 激活的 PYK2 通过 STAT3-VGF 轴促进非小细胞肺癌的进展。
Cell Commun Signal. 2024 Jun 6;22(1):313. doi: 10.1186/s12964-024-01639-1.
3
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.微小RNA-200a调控程序性死亡受体配体1,并预测晚期非小细胞肺癌对免疫检查点抑制剂的反应。
Transl Lung Cancer Res. 2025 Jul 31;14(7):2522-2536. doi: 10.21037/tlcr-2025-117. Epub 2025 Jul 28.
4
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
5
Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells.烟草特异性亚硝胺NNK通过烟碱样受体介导激活Raf-1/丝裂原活化蛋白激酶途径,导致人小细胞肺癌细胞和肺神经内分泌细胞中的c-myc磷酸化。
J Cancer Res Clin Oncol. 2001 Dec;127(12):707-17. doi: 10.1007/s004320100289.
6
[Expression of SIPA1 in colorectal cancer and its impact on its biological behavior].[信号通路抑制因子1在结直肠癌中的表达及其对其生物学行为的影响]
Zhonghua Zhong Liu Za Zhi. 2025 Jul 23;47(7):657-668. doi: 10.3760/cma.j.cn112152-20240812-00338.
7
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
8
PD-L1 expression and its association with clinicopathological and computed tomography features in surgically resected non-small cell lung cancer: a retrospective cohort study.手术切除的非小细胞肺癌中PD-L1表达及其与临床病理和计算机断层扫描特征的相关性:一项回顾性队列研究
Sci Rep. 2025 Jul 7;15(1):24323. doi: 10.1038/s41598-025-10437-9.
9
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesions.表征肺鳞状细胞癌驱动突变的基因特征可预测癌前病变的进展。
bioRxiv. 2025 Jul 30:2025.07.29.664792. doi: 10.1101/2025.07.29.664792.
10
MiR-1976 affects lung squamous cell carcinoma development by targeting NCAPH.微小RNA-1976通过靶向核仁分裂相关蛋白(NCAPH)影响肺鳞状细胞癌的发展。
J Appl Genet. 2025 Jul 23. doi: 10.1007/s13353-025-00990-4.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment.PD-1 和 PD-L1:免疫交响乐的建筑师和癌症治疗免疫疗法突破的推动者。
Front Immunol. 2023 Dec 1;14:1296341. doi: 10.3389/fimmu.2023.1296341. eCollection 2023.
3
Contribution of the α5 nAChR Subunit and α5SNP to Nicotine-Induced Proliferation and Migration of Human Cancer Cells.α5烟碱型乙酰胆碱受体亚基和α5单核苷酸多态性对尼古丁诱导的人癌细胞增殖和迁移的作用
Cells. 2023 Aug 4;12(15):2000. doi: 10.3390/cells12152000.
4
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma.不同烟碱型乙酰胆碱受体、程序性死亡配体1及多巴胺受体D2在肺腺癌中的表达、相关性及预后意义
Front Oncol. 2022 Aug 22;12:959500. doi: 10.3389/fonc.2022.959500. eCollection 2022.
5
Calmodulin 2 Facilitates Angiogenesis and Metastasis of Gastric Cancer STAT3/HIF-1A/VEGF-A Mediated Macrophage Polarization.钙调蛋白2通过STAT3/HIF-1A/VEGF-A介导的巨噬细胞极化促进胃癌血管生成和转移。
Front Oncol. 2021 Sep 15;11:727306. doi: 10.3389/fonc.2021.727306. eCollection 2021.
6
Electroacupuncture ameliorates intestinal inflammation by activating α7nAChR-mediated JAK2/STAT3 signaling pathway in postoperative ileus.电针通过激活术后肠梗阻中α7烟碱型乙酰胆碱受体介导的JAK2/STAT3信号通路改善肠道炎症。
Theranostics. 2021 Feb 19;11(9):4078-4089. doi: 10.7150/thno.52574. eCollection 2021.
7
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.ILT4 抑制可预防 TAM 和功能失调 T 细胞介导的免疫抑制,并增强 EGFR 激活的 NSCLC 中抗 PD-L1 治疗的疗效。
Theranostics. 2021 Jan 19;11(7):3392-3416. doi: 10.7150/thno.52435. eCollection 2021.
8
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.PACIFIC 试验的更新:放化疗后 durvalumab 治疗 III 期非小细胞肺癌的 4 年生存结果
J Thorac Oncol. 2021 May;16(5):860-867. doi: 10.1016/j.jtho.2020.12.015. Epub 2021 Jan 19.
9
Smoking status-based efficacy difference in anti-PD-1/PD-L1 immunotherapy: a systematic review and meta-analysis.基于吸烟状况的抗 PD-1/PD-L1 免疫治疗疗效差异:系统评价和荟萃分析。
Immunotherapy. 2020 Dec;12(18):1313-1324. doi: 10.2217/imt-2020-0007. Epub 2020 Oct 5.
10
Targeting STAT3 in Cancer Immunotherapy.靶向 STAT3 在癌症免疫治疗中的作用。
Mol Cancer. 2020 Sep 24;19(1):145. doi: 10.1186/s12943-020-01258-7.